• 49929 Citations
  • 108 Scopus h-Index
1981 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Comment/debate
2020

Exhausted and outnumbered: CD4+ T cells in the myeloma battlefield

Manasanch, E. E. & Gertz, M. A., 2020, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalComment/debate

Non-transplant eligible multiple myeloma: deciphering optimal first line regimens

Vaxman, I. & Gertz, M., Feb 23 2020, In : Leukemia and Lymphoma. 61, 3, p. 504-506 3 p.

Research output: Contribution to journalComment/debate

2019

Correction: Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond (Leukemia, (2018), 32, 2, (252-262), 10.1038/leu.2017.329)

Chim, C. S., Kumar, S. K., Orlowski, R. Z., Cook, G., Richardson, P. G., Gertz, M. A., Giralt, S., Mateos, M. V., Leleu, X. & Anderson, K. C., Apr 1 2019, In : Leukemia. 33, 4, p. 1058-1059 2 p.

Research output: Contribution to journalComment/debate

Open Access
Open Access

Current role of high dose chemotherapy in the management of multiple myeloma

Gertz, M. A., May 12 2019, In : Leukemia and Lymphoma. 60, 6, p. 1349-1351 3 p.

Research output: Contribution to journalComment/debate

How i treat cold agglutinin hemolytic anemia

Gertz, M., Jun 1 2019, In : Clinical Advances in Hematology and Oncology. 17, 6, p. 338-343 6 p.

Research output: Contribution to journalComment/debate

Joint Pain and Proteinuria

Al Saleh, A. S., Sidiqi, M. H. & Gertz, M. A., Oct 15 2019, In : JAMA - Journal of the American Medical Association. 322, 15, p. 1512-1513 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Management of induction failures in newly diagnosed transplant-eligible multiple myeloma

Gertz, M. A., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalComment/debate

1 Scopus citations

The colorful landscape of multiple myeloma

Muchtar, E. & Gertz, M. A., Jul 29 2019, In : Leukemia and Lymphoma. 60, 9, p. 2099-2100 2 p.

Research output: Contribution to journalComment/debate

2018

Testicular plasmacytoma: unique location or circumstantial presentation?

Muchtar, E., Bladé, J. & Gertz, M., Aug 3 2018, In : Leukemia and Lymphoma. 59, 8, p. 1769-1771 3 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Will we be able to afford a cure in multiple myeloma?

Chakraborty, R. & Gertz, M., Jan 2 2018, In : Leukemia and Lymphoma. 59, 1, p. 1-2 2 p.

Research output: Contribution to journalComment/debate

2017

+1q: amplifying the bad genes in myeloma

Chakraborty, R. & Gertz, M., Aug 3 2017, In : Leukemia and Lymphoma. 58, 8, p. 1771-1773 3 p.

Research output: Contribution to journalComment/debate

3 Scopus citations
2016

Life beyond bortezomib: Increasing treatment options in refractory myeloma

Chakraborty, R. & Gertz, M., Jun 2 2016, In : Leukemia and Lymphoma. 57, 6, p. 1251-1253 3 p.

Research output: Contribution to journalComment/debate

Lymphoplasmacytic lymphoma: What we need to know

Chakraborty, R. & Gertz, M., May 3 2016, In : Leukemia and Lymphoma. 57, 5, p. 991-992 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Panobinostat in multiple myeloma

Gertz, M., Dec 1 2016, In : The Lancet Haematology. 3, 12, p. e552-e553

Research output: Contribution to journalComment/debate

4 Scopus citations

Utility of immunophenotyping of plasma cells in multiple myeloma

Gertz, M. & Buadi, F. K., Feb 1 2016, In : Leukemia and Lymphoma. 57, 2, p. 252-253 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2015

The role of bendamustine in the management of plasma cell myeloma

Gertz, M., Jan 1 2015, In : Leukemia and Lymphoma. 56, 5, p. 1195-1196 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Utility of the immunoglobulin free light chain assay for plasma cell disorders 2015

Gertz, M., Jan 1 2015, In : Leukemia and Lymphoma. 56, 10, p. 2757-2758 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2014

Bortezomib-based combination regimens in myeloma: More is not necessarily better

Gonsalves, W. I. & Gertz, M. A., Jul 2014, In : Leukemia and Lymphoma. 55, 7, p. 1439-1440 2 p.

Research output: Contribution to journalComment/debate

Potential new risks of lenalidomide

Gertz, M. A. & Buadi, F. K., Sep 2014, In : Leukemia and Lymphoma. 55, 9, p. 1962-1963 2 p.

Research output: Contribution to journalComment/debate

Risk adapted therapy for multiple myeloma: Back to basics

Kumar, S. K. & Gertz, M. A., Oct 1 2014, In : Leukemia and Lymphoma. 55, 10, p. 2219-2220 2 p.

Research output: Contribution to journalComment/debate

8 Scopus citations
2013

Allaying and alleviating amyloid agony and anxiety.

Gertz, M. A., Apr 25 2013, In : Unknown Journal. 121, 17, p. 3301-3302 2 p.

Research output: Contribution to journalComment/debate

4 Scopus citations

Pomalidomide and myeloma meningitis

Gertz, M. A., Apr 1 2013, In : Leukemia and Lymphoma. 54, 4, p. 681-682 2 p.

Research output: Contribution to journalComment/debate

6 Scopus citations

Salvage autologous stem cell transplant is an effective regimen for relapsed multiple myeloma

Gertz, M. A. & Lacy, M. Q., Oct 1 2013, In : Leukemia and Lymphoma. 54, 10, p. 2096-2097 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

What is Waldenström macroglobulinemia?

Gertz, M. A., Oct 21 2013, In : Leukemia and Lymphoma. 54, 11, p. 2345-2346 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2012

Baby, it's cold outside!

Gertz, M. A., Jun 21 2012, In : Blood. 119, 25, p. 5943-5944 2 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

Managing light chain deposition disease

Gertz, M. A., Feb 1 2012, In : Leukemia and Lymphoma. 53, 2, p. 183-184 2 p.

Research output: Contribution to journalComment/debate

11 Scopus citations

The spectrum of monoclonal gammopathies affecting the kidney

Leung, N. & Gertz, M. A., Sep 1 2012, In : Leukemia and Lymphoma. 53, 9, p. 1656-1657 2 p.

Research output: Contribution to journalComment/debate

3 Scopus citations
2011

Deciding on the therapy of multiple myeloma using genetic risk stratification

Gertz, M. A., Feb 1 2011, In : Leukemia and Lymphoma. 52, 2, p. 157-158 2 p.

Research output: Contribution to journalComment/debate

Reducing neurotoxicity in the management of multiple myeloma

Gertz, M. A., Nov 1 2011, In : Leukemia and Lymphoma. 52, 11, p. 2043-2044 2 p.

Research output: Contribution to journalComment/debate

Stem cell transplant: An effective salvage therapy for multiple myeloma

Gertz, M. A., Aug 1 2011, In : Leukemia and Lymphoma. 52, 8, p. 1413-1414 2 p.

Research output: Contribution to journalComment/debate

4 Scopus citations

The role of bisphosphonate therapy in the global management of multiple myeloma

Gertz, M. A., May 1 2011, In : Leukemia and Lymphoma. 52, 5, p. 736-737 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations
2010

Herbs for hematology

Gertz, M. A., Aug 1 2010, In : Leukemia and Lymphoma. 51, 8, p. 1389-1390 2 p.

Research output: Contribution to journalComment/debate

I don't know how to treat amyloidosis

Gertz, M. A., Jul 29 2010, In : Blood. 116, 4, p. 507-508 2 p.

Research output: Contribution to journalComment/debate

23 Scopus citations

Individualizing cancer therapy

Gertz, M. A. & Tadmor, T., Sep 1 2010, In : Leukemia and Lymphoma. 51, 9, p. 1585-1587 3 p.

Research output: Contribution to journalComment/debate

Managing tumor lysis syndrome in 2010

Gertz, M. A., Feb 1 2010, In : Leukemia and Lymphoma. 51, 2, p. 179-180 2 p.

Research output: Contribution to journalComment/debate

16 Scopus citations

Waldenström macroglobulinemia: Is newer really better?

Gertz, M. A., Dec 1 2010, In : Leukemia and Lymphoma. 51, 12, p. 2152-2153 2 p.

Research output: Contribution to journalComment/debate

3 Scopus citations

What's new in Waldenstrm macroglobulinemia

Gertz, M. A., Oct 1 2010, In : Leukemia and Lymphoma. 51, 10, p. 1765-1766 2 p.

Research output: Contribution to journalComment/debate

You should see the other guy

Gertz, M. A., Sep 30 2010, In : Blood. 116, 13, p. 2199-2200 2 p.

Research output: Contribution to journalComment/debate

2009

Caring for the terminally ill patient with hematologic malignancies

Gertz, M. A., Jul 27 2009, In : Leukemia and Lymphoma. 50, 3, p. 313-314 2 p.

Research output: Contribution to journalComment/debate

1 Scopus citations

Finishing off fibrils

Gertz, M., Nov 19 2009, In : Blood. 114, 8, p. 1456-1457 2 p.

Research output: Contribution to journalComment/debate

2 Scopus citations

Is antisense nonsense?

Gertz, M. A., Aug 17 2009, In : Leukemia and Lymphoma. 50, 4, p. 519-520 2 p.

Research output: Contribution to journalComment/debate

2008

Critiquing Cryos

Gertz, M., Jun 1 2008, In : Blood. 111, 11, 1 p.

Research output: Contribution to journalComment/debate

Current therapy of myeloma induced renal failure

Gertz, M., May 1 2008, In : Leukemia and Lymphoma. 49, 5, p. 833-834 2 p.

Research output: Contribution to journalComment/debate

7 Scopus citations

The dilemma of jaw osteonecrosis in patients with multiple myeloma

Gertz, M. A. & Koka, S., Dec 5 2008, In : Leukemia and Lymphoma. 49, 11, p. 2037-2039 3 p.

Research output: Contribution to journalComment/debate

1 Scopus citations